TrialInternational journal of molecular sciences2024
Post-Hoc Analysis of Potential Correlates of Protection of a Recombinant SARS-CoV-2 Spike Protein Extracellular Domain Vaccine Formulated with Advax-CpG55.2-Adjuvant.
Nikolai PetrovskyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.